UPMC Hillman Cancer Center

Greg Delgoffe in a striped white shirt
A study led by immunology’s Greg Delgoffe and published in Nature shows how chemicals in the areas surrounding tumors subvert the immune system and enable cancer to evade attack. These findings suggest that an existing drug could boost cancer immunotherapy.
an artist's depiction of the gut biome
Changing the bacteria in the gut can help patients with advanced melanoma respond to immunotherapy, according to a Pitt-UPMC study published in Science.
Elsie and Henry Hillman at the opening of the cancer center
The Henry L. Hillman Foundation has made a commitment of $3 million per year for 10 years for ongoing support of the Hillman Fellows for Innovative Cancer Research Program, where researchers cultivate novel cancer discoveries that improve patient care.
Vignali smiling
The discovery shows that the immune system can be tweaked in order to find and destroy cancer cells more effectively.
Robert L. Ferris, a 15-year veteran of the UPMC Hillman Cancer Center, head and neck cancer specialist and a leading voice in immunotherapy, begins July 1.
The legacy built by Henry Hillman and his family will resound for generations, not only at the University of Pittsburgh but also throughout the region.